[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100574590":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":8,"locations":14,"responsibleParty":45,"collaborators":7,"id":47,"slug":48,"hasResults":49,"nctId":50,"briefTitle":51,"officialTitle":51,"acronym":52,"eligibilityCriteria":53,"healthyVolunteers":49,"sex":54,"minAge":7,"maxAge":55,"enrollmentInfo":56,"targetDuration":7,"studyType":59,"phases":7,"briefSummary":60,"conditions":61,"keywords":63,"overallStatus":17,"whyStopped":7,"lastUpdateSubmitDate":64,"lastUpdatePostDateStruct":65,"startDateStruct":68,"completionDateStruct":70,"leadSponsor":72,"locationsCount":73},{"fullName":5,"class":6},"IRCCS Azienda Ospedaliero-Universitaria di Bologna","OTHER",null,[9],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},"Arianna Dondi","CONTACT","0512143012","arianna.dondi@aosp.bo.it",[15,36],{"facility":16,"status":17,"city":18,"state":7,"zip":19,"country":20,"countryCode":21,"cosmosGeoPoint":22,"geoPoint":27,"contacts":28},"Azienda USL di Bologna Ospedale Maggiore","RECRUITING","Bologna","40124","Italy","IT",{"type":23,"coordinates":24},"Point",[25,26],11.33875,44.49381,{"lat":26,"lon":25},[29,34],{"name":30,"role":11,"phone":31,"phoneExt":32,"email":33},"Francesca Sbravati, MD","0512143643","+39","francesca.sbravati@ausl.bologna.it",{"name":30,"role":35,"phone":7,"phoneExt":7,"email":7},"PRINCIPAL_INVESTIGATOR",{"facility":37,"status":17,"city":18,"state":7,"zip":38,"country":20,"countryCode":21,"cosmosGeoPoint":39,"geoPoint":41,"contacts":42},"IRCCS Azienda Ospedaliero - Universitaria di Bologna","40138",{"type":23,"coordinates":40},[25,26],{"lat":26,"lon":25},[43],{"name":44,"role":11,"phone":12,"phoneExt":12,"email":13},"Arianna Dondi, MD",{"type":46,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100574590","acute-hepatitis-in-pediatrics-100574590",false,"NCT06761261","Acute Hepatitis in Pediatrics","LIVERPED","Inclusion Criteria:\n\n* Age between 0 and 17 years (extremes included).\n* Access to PSP and\u002For hospitalized (OBI or hospitalization)\n* Diagnosis of acute hepatitis\n\nExclusion Criteria:\n\n* Refusal of the parent\u002Fguardian to participate in the study.\n* Mild hypertransaminasemia (\\<5 times the upper limit of normal) in a patient with known chronic liver dysfunction (e.g. liver cirrhosis).\n* Neonatal jaundice without hepatocyte involvement or signs of cholestasis (prevalence of indirect bilirubin with normal AST, ALT and GGT).","ALL","17 Years",{"count":57,"type":58},437,"ESTIMATED","OBSERVATIONAL","This study aims to investigate wich symptoms and blood test characteristics acute hepatitis manifests in pediatric age. The study will be conducted because acute hepatitis is not an easily and clearly recognized disease in children.\n\nThis study aims to better characterize this disease by describing the frequency of the different symptoms with which it can manifest and the changes it causes in blood tests. It also aims to assess the occurrence of any complications of pediatric acute hepatitis.\n\nThe study is observational, so it is limited to collecting data and analyzing the patient's clinical course without interfering with normal clinical practice.",[62],"Hepatitis",[62],"2024-12-30",{"date":66,"type":67},"2025-01-07","ACTUAL",{"date":69,"type":67},"2023-10-16",{"date":71,"type":58},"2028-12-31",{"name":5,"class":6},2]